Kathryn E. Wengel - 10 Jun 2022 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role
EVP, Chief GSC Officer
Signature
Raavi K. Deol, as attorney-in-fact for Kathryn E. Wengel
Issuer symbol
JNJ
Transactions as of
10 Jun 2022
Net transactions value
-$4,018,440
Form type
4
Filing time
14 Jun 2022, 18:28:39 UTC
Previous filing
29 Mar 2022
Next filing
10 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JNJ Common Stock Options Exercise $2,901,600 +40,000 +56% $72.54 111,311 10 Jun 2022 Direct
transaction JNJ Common Stock Sale $17,300 -100 -0.09% $173.00 111,211 10 Jun 2022 Direct F1
transaction JNJ Common Stock Sale $30,102 -174 -0.16% $173.00 111,037 10 Jun 2022 Direct F1
transaction JNJ Common Stock Sale $1,141,807 -6,600 -5.9% $173.00 104,437 10 Jun 2022 Direct F1
transaction JNJ Common Stock Sale $5,730,831 -33,126 -32% $173.00 71,311 10 Jun 2022 Direct F1
holding JNJ Common Stock 50 10 Jun 2022 By 401k F2
holding JNJ Common Stock 281 10 Jun 2022 By ESOP F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JNJ Employee Stock Options (Right to Buy) Options Exercise $0 -40,000 -71% $0.000000 16,410 10 Jun 2022 Common Stock 40,000 $72.54 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from 173.00 to 173.02 . The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (5/31/2022)
F3 Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (5/31/2022)